Veralox Therapeutics Inc. reported raising $1.46 Million in an initial SEC Form D filing, from an offering of $4 Million
Amount Raised
$1.46 Million
Round Type
Seed
FrederickBiotechnologyQuick answer
VLX-1005 raised $1.46 Million in a Seed round, dated May 22, 2019. VLX-1005 is based in Frederick, Maryland, United States.
- How much did VLX-1005 raise?
- VLX-1005 raised $1.46 Million in a Seed round on May 22, 2019.
- What does VLX-1005 do?
- VLX-1005 is a Phase 2 drug candidate indicated for heparin-induced thrombocytopenia (HIT).
- Where is VLX-1005 based and how big is it?
- VLX-1005 is based in Frederick, Maryland, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as VLX-1005 that raised within 45 days of this round, from Fundz verified event records.
- TuHURA Biosciences raised $495K (Seed) on July 3, 2019.
- Inari raised $70M on July 3, 2019.
- Novabay raised $2.4M on July 3, 2019.
- Eccrine Systems, Inc. raised $622K (Seed) on July 3, 2019.
- Venus Concept Ltd. raised $7.8M on July 3, 2019.
- ProtoKinetix raised $272K on July 2, 2019.
Who to call at VLX-1005, and when
A new round usually means VLX-1005 is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VLX-1005 raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VLX-1005, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VLX-1005. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VLX-1005 raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
VLX-1005 raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.